|
|
|
Insider
Information: |
Gadicke Ansbert |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
30,197 |
|
Indirect Shares
|
56,162,356 |
|
|
Direct
Value |
$22,204 |
|
|
Indirect Value
|
$184,466,517 |
|
|
Total
Shares |
56,192,553 |
|
|
Total
Value |
$184,488,721 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
Former 10% Owner |
2004-07-02 |
0 |
2004-09-13 |
475,026 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
Director, 10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
Radius Health Inc. |
RDUS |
Director |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Former 10% Owner |
|
0 |
2013-03-11 |
2,790,479 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2012-02-01 |
0 |
2012-02-01 |
3,740 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
2012-06-05 |
0 |
2012-07-09 |
1,275,886 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,388,165 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
8,422,847 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
Director, 10% Owner |
2019-02-19 |
0 |
2023-06-01 |
0 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2021-07-12 |
3,882,485 |
Premium* |
|
Allovir Inc |
ALVR |
Director, 10% Owner |
2022-07-28 |
30,197 |
2022-07-28 |
16,674,766 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
10% Owner |
2020-09-21 |
0 |
2020-09-21 |
91,081 |
Premium* |
|
Oncorus, Inc. |
ONCR |
10% Owner |
|
0 |
2020-10-06 |
2,377,025 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VSTM |
Verastem, Inc. |
Director |
|
2012-02-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,933,333 |
1,933,333 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2012-02-01 |
4 |
B |
$10.00 |
$1,000,000 |
I/I |
100,000 |
3,740 |
2.1 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
Director |
|
2019-02-19 |
4 |
B |
$15.00 |
$20,599,995 |
I/I |
1,373,333 |
1,569,235 |
2.25 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
Director |
|
2019-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
5,852,612 |
2,704,315 |
0 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
Director |
|
2023-05-22 |
4 |
OE |
$0.74 |
$131,919 |
I/I |
178,269 |
374,171 |
0 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
Director |
|
2023-05-22 |
4 |
S |
$1.88 |
$131,920 |
I/I |
(70,170) |
304,001 |
0 |
% |
|
TCRR |
Tcr2 Therapeutics Inc. |
Director |
|
2023-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,529,946) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-05 |
4 |
S |
$0.29 |
$8,571 |
I/I |
(29,555) |
3,791,585 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-06 |
4 |
S |
$0.29 |
$2,436 |
I/I |
(8,400) |
3,783,185 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-15 |
4 |
S |
$0.29 |
$421 |
I/I |
(1,450) |
3,781,735 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-19 |
4 |
S |
$0.29 |
$3,480 |
I/I |
(12,000) |
3,759,735 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-28 |
4 |
S |
$0.29 |
$5,655 |
I/I |
(19,500) |
3,750,235 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-07-02 |
4 |
S |
$0.29 |
$23,301 |
I/I |
(80,348) |
3,669,887 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-07-03 |
4 |
S |
$0.29 |
$28,481 |
I/I |
(98,210) |
3,571,677 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-07-06 |
4 |
S |
$0.29 |
$195,324 |
I/I |
(671,217) |
2,900,460 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-07-09 |
4 |
S |
$0.31 |
$498,744 |
I/I |
(1,624,574) |
1,275,886 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2020-06-23 |
4 |
B |
$20.00 |
$10,000,000 |
I/I |
500,000 |
5,392,109 |
1.5 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2020-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
4,892,109 |
4,892,109 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-03-12 |
4 |
S |
$28.18 |
$19,585,100 |
I/I |
(695,000) |
4,697,109 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
24,271 |
4,672,838 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(21,834) |
4,627,600 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-18 |
4 |
AS |
$33.90 |
$799,571 |
I/I |
(23,404) |
4,649,434 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-19 |
4 |
AS |
$34.23 |
$466,965 |
I/I |
(13,543) |
4,614,057 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-20 |
4 |
AS |
$34.66 |
$345,428 |
I/I |
(9,957) |
4,604,100 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-21 |
4 |
AS |
$34.80 |
$10,532,881 |
I/I |
(302,669) |
4,301,431 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|